Table 1 Demographic and clinical features of BOT patients
From: Identification of factors that impact recurrence in patients with borderline ovarian tumors
Variables | Â | N (%) |
|---|---|---|
Age (range 15–87 years) | ≤40 | 78 (44.1) |
>40 | 99 (55.9) | |
Multiparous | Â | 30 (16.9) |
Nulliparous | Â | 148 (83.1) |
CA199 | <35 U/ml | 117 (65.7) |
≥35 U/ml | 50 (28.1) | |
N/A | 3 (1.7) | |
CA125 | <35 U/ml | 78 (43.8) |
≥35 U/ml | 90 (50.6) | |
N/A | 10 (5.6) | |
CEA | <3.4 U/ml | 138 (77.5) |
≥3.4 U/ml | 28 (15.8) | |
N/A | 12 (6.7) | |
HE4 | <105 U/ml | 131 (73.6) |
≥105 U/ml | 35 (19.7) | |
N/A | 12 (6.7) | |
Fertility-preserving | Â | 68 (38.4) |
 USO | 33 (18.6) | |
 USO + CC | 14 (7.9) | |
 BC | 21 (11.9) | |
Radical surgery | Â | 109 (61.6) |
Lymphadenectomy | Yes | 99 (56.2%) |
No | 77 (43.8%) | |
Restaging | Yes | 60 (33.7) |
No | 116 (65.2) | |
N/A | 2 (1.1) | |
Rupture | Yes | 30 (16.9) |
No | 66 (36.3) | |
N/A | 84 (46.1) | |
Ascites | Positive | 19 (10.7) |
Negative | 107 (60.1) | |
N/A | 52 (29.2) | |
Surgery approach | Open | 166 (93.2) |
Laparoscopic | 10 (5.6) | |
Laparoscopic to open | 2 (1.2) | |
Chemotherapy | Yes | 23 (12.9) |
No | 157 (87.1) | |
Recurrence | Â | 32 (18.0) |
Death | Â | 5 (2.8) |